This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Intravascular Ultrasound for Hepatocellular Carcinoma Staging

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2007 by University Hospital, Geneva.
Recruitment status was:  Recruiting
Information provided by:
University Hospital, Geneva Identifier:
First received: May 15, 2007
Last updated: May 16, 2007
Last verified: May 2007

To diagnose hepatocellular carcinoma (HCC) and to determine the extent of the disease, a triphasic CT scan or a magnetic resonance imaging are required. The characterization of hepatic nodules is more difficult when the HCC lesions have a diameter of less than 2 cm.

Since accuracy in the assessment of the number and the size of HCC nodules, as well as of the invasion of blood vessels is crucial to determine outcome after liver transplantation due to tumour recurrence, there is a need for techniques with a higher definition potential.

As a consequence, to improve outcome and to optimize organ allocation, patients on the liver transplantation waiting list might benefit from intravascular ultrasound as an additional examination to complete the pre-transplant tumour staging process.

Condition Intervention
Hepatocellular Carcinoma Device: Intravascular ultrasound of the liver

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Intravascular Ultrasound for the Staging of Hepatocellular Carcinoma: a Pilot Study

Resource links provided by NLM:

Further study details as provided by University Hospital, Geneva:

Study Start Date: May 2007
Estimated Study Completion Date: September 2007

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • hepatocellular carcinoma nodules
  • patient on liver transplantation waiting list
  • written informed consent

Exclusion Criteria:

  • thrombosis of hepatic veins or vena cava
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00474734

Contact: Antoine Hadengue, Prof. +41 22 37 29 340

University Hospital Geneva Recruiting
Geneva, Switzerland
Contact: Andrea De Gottardi, MD PhD    +41 22 37 29 256   
Sponsors and Collaborators
University Hospital, Geneva
Study Chair: Antoine Hadengue, Prof. University Hospital, Geneva
  More Information Identifier: NCT00474734     History of Changes
Obsolete Identifiers: NCT00472979
Other Study ID Numbers: 07-063
Study First Received: May 15, 2007
Last Updated: May 16, 2007

Keywords provided by University Hospital, Geneva:
hepatocellular carcinoma
liver transplantation
intravascular ultrasound

Additional relevant MeSH terms:
Carcinoma, Hepatocellular
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Liver Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Liver Diseases processed this record on September 21, 2017